CA1306694C - Preparation pharmaceutique et methode d'inhibition de la replication du virus htlv-iii (sida) - Google Patents

Preparation pharmaceutique et methode d'inhibition de la replication du virus htlv-iii (sida)

Info

Publication number
CA1306694C
CA1306694C CA000573644A CA573644A CA1306694C CA 1306694 C CA1306694 C CA 1306694C CA 000573644 A CA000573644 A CA 000573644A CA 573644 A CA573644 A CA 573644A CA 1306694 C CA1306694 C CA 1306694C
Authority
CA
Canada
Prior art keywords
dextran sulfate
pharmaceutical preparation
htlv
hydrogenated dextran
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000573644A
Other languages
English (en)
Inventor
Thomas C. Usher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dextran Products Ltd
Original Assignee
Dextran Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dextran Products Ltd filed Critical Dextran Products Ltd
Priority to CA000573644A priority Critical patent/CA1306694C/fr
Priority to ZA891535A priority patent/ZA891535B/xx
Application granted granted Critical
Publication of CA1306694C publication Critical patent/CA1306694C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000573644A 1988-08-02 1988-08-02 Preparation pharmaceutique et methode d'inhibition de la replication du virus htlv-iii (sida) Expired - Lifetime CA1306694C (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA000573644A CA1306694C (fr) 1988-08-02 1988-08-02 Preparation pharmaceutique et methode d'inhibition de la replication du virus htlv-iii (sida)
ZA891535A ZA891535B (en) 1988-08-02 1989-02-28 Dextran sulphate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000573644A CA1306694C (fr) 1988-08-02 1988-08-02 Preparation pharmaceutique et methode d'inhibition de la replication du virus htlv-iii (sida)

Publications (1)

Publication Number Publication Date
CA1306694C true CA1306694C (fr) 1992-08-25

Family

ID=4138477

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000573644A Expired - Lifetime CA1306694C (fr) 1988-08-02 1988-08-02 Preparation pharmaceutique et methode d'inhibition de la replication du virus htlv-iii (sida)

Country Status (2)

Country Link
CA (1) CA1306694C (fr)
ZA (1) ZA891535B (fr)

Also Published As

Publication number Publication date
ZA891535B (en) 1989-11-29

Similar Documents

Publication Publication Date Title
Sarin et al. Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone
Harakeh et al. Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells.
Soudeyns et al. Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog
Nakashima et al. Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro
Ito et al. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)]
DE3650377T2 (de) Regulierung der retroviralen replikation, infektion und pathogenese.
AT401470B (de) Pharmazeutische verwendung von 17-ketosteroiden
Gram et al. Valproate sodium: a controlled clinical trial including monitoring of drug levels
DE3886710T2 (de) Verfahren zur selektiven inhibierung von hiv.
US5246970A (en) Method of inhibiting nitric oxide formation
Balzarini et al. Anti‐retrovirus activity of 9‐(2‐phosphonylmethoxyethyl) adenine (PMEA) in vivo increases when it is less frequently administered
TURANO et al. Inhibitory effect of papaverine on HIV replication in vitro
AU640511B2 (en) Hexa-n-(o-hydroxybenzyl) neomycin b for inhibiting human retroviruses and for the treatment of aids
US5026726A (en) Gossylic iminolactones and gossylic lactones and their anti-viral activities
DE68914990T2 (de) Verfahren zur inhibierung der wirkung des menschlichen immunschwäche-virus (hiv) in vivo.
KR20000069296A (ko) 항바이러스 활성을 갖는 살비아 종의 추출물
DE60118592T2 (de) Verbindungen aus phyllanthus zur prävention und/oder behandlung von erkrankungen im zusammenhang mit einem retrovirus
US5057325A (en) Method of inhibiting replication of HIV with water-soluble melanins
CA1306694C (fr) Preparation pharmaceutique et methode d'inhibition de la replication du virus htlv-iii (sida)
Ruprecht et al. Castanospermine vs. its 6-O-butanoyl analog: a comparison of toxicity and antiviral activity in vitro and in vivo
EP0183352A2 (fr) Utilisation de suramine pour clinothérapie des infections par quelques-uns des membres de la famille des virus humains leucémiques de cellules-T (HTLV) y compris le virus lymphadénopathique (LAV)
JPH05504774A (ja) エイズ治療を増進するためのメタロポルフィリン類の使用
DE19813802A1 (de) Anti-virale Wirkung von Propolis durch Inhibition viraler Nukleinsäure Polymerasen
IL106491A (en) A preparation based on fibuperrin for use in the treatment of the virus
Anand et al. Interaction between rifabutin and human immunodeficiency virus type 1: inhibition of replication, cytopathic effect, and reverse transcriptase in vitro

Legal Events

Date Code Title Description
MKEX Expiry